Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
AUPH
AUPH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AUPH News
Aurinia and Vornado Executives Make Significant Stock Purchases
6d ago
NASDAQ.COM
Aurinia Pharmaceuticals Q4 Earnings Beat Expectations
Feb 26 2026
Benzinga
Aurinia Pharmaceuticals Reports Strong Q4 2025 Earnings and 2026 Outlook
Feb 26 2026
seekingalpha
Aurinia Pharmaceuticals Q4 Earnings Beat Expectations
Feb 26 2026
stocktwits
Aurinia Pharmaceuticals Q4 Earnings Beat Expectations
Feb 26 2026
seekingalpha
Aurinia Pharma to Announce Q4 Earnings on February 26
Feb 25 2026
seekingalpha
Aurinia Pharmaceuticals to Report Financial Results on February 26, 2026
Feb 19 2026
Newsfilter
Reasons to Consider Aurinia Pharmaceuticals (AUPH) as a Strong Momentum Stock: Is It Time to Buy?
Dec 05 2025
NASDAQ.COM
Examining Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation Following Recent Increase in Share Price
Nov 30 2025
Yahoo Finance
Inaugural Week of AUPH Options Trading for July 2026
Nov 24 2025
NASDAQ.COM
Aurinia Pharmaceuticals Stock Increases Following Jefferies Upgrade
Nov 07 2025
Yahoo Finance
Editorial | The FDA's Crisis Intensifies
Nov 06 2025
WSJ
Analysis | Democrats Shine in the Evening
Nov 05 2025
WSJ
Aurinia Pharmaceuticals Shares Rise 7% Following Strong Q3 Revenue and Upgraded Forecast
Nov 04 2025
NASDAQ.COM
Aurinia Pharma Reports Surge in Q3 Earnings; Pre-market Stock Rises and Annual Forecast Upgraded
Nov 04 2025
NASDAQ.COM
Aurinia Pharmaceuticals Announces Financial Results for Q3 and Year-to-Date Ending September 30, 2025, Along with Recent Business Developments
Nov 04 2025
Newsfilter
Show More News
